✦ LIBER ✦

The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program

✍ Scribed by Stuart Pocock; Duolao Wang; Lars Wilhelmsen; Charles H. Hennekens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Candesartan in heart failure—assessment

✍ Karl Swedberg; Marc Pfeffer; Chris Granger; Peter Held; John Mcmurray; Gunilla O 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 692 KB

Prevention of atrial fibrillation in pat

✍ Anique Ducharme; Karl Swedberg; Marc A. Pfeffer; Alain Cohen-Solal; Christopher 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Effect of candesartan on New York Heart

✍ E. O’Meara; S. Solomon; J. McMurray 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 36 KB

ACE Inhibitor Intolerance and Lessons Le

✍ Domenic A. Sica 📂 Article 📅 2004 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 305 KB

Days alive and out of hospital and the p

✍ Cono A. Ariti; John G.F. Cleland; Stuart J. Pocock; Marc A. Pfeffer; Karl Swedbe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 229 KB

PCV84 Resource Utilization and Costs for

✍ F.M. Fruhwald; A.D. Vavrovsky 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB